List of SBIR/STTR awards granted to EVON MEDICS, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to EVON MEDICS, LLC in May, 2021 for $1,247,784.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG061981-03A1 | Phase II | 1,247,784 | May 1, 2021 | |||||||
A SBIR Phase I contract was awarded to EVON MEDICS, LLC in September, 2022 for $499,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NS125745-01A1 | Phase I | 499,999 | September 20, 2022 | |||||||
A SBIR Phase I contract was awarded to EVON MEDICS, LLC in September, 2018 for $450,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG061981-01 | Phase I | 450,000 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to EVON MEDICS, LLC in September, 2020 for $820,883.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DA049616-02 | Phase II | 820,883 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to EVON MEDICS, LLC in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA049616-01 | Phase I | 225,000 | September 30, 2019 | |||||||
A SBIR Phase I contract was awarded to EVON MEDICS, LLC in May, 2022 for $330,680.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DA056156-01 | Phase I | 330,680 | May 1, 2022 | |||||||
A SBIR Phase I contract was awarded to EVON MEDICS, LLC in August, 2023 for $448,887.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG082621-01 | Phase I | 448,887 | August 1, 2023 | |||||||
A SBIR Phase II contract was awarded to EVON MEDICS, LLC in July, 2023 for $1,318,829.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DA056156-02 | Phase II | 1,318,829 | July 1, 2023 |
